US 8470312
Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
granted A61KA61K31/282A61K31/555
Quick answer
US patent 8470312 (Abrogating proinflammatory cytokine production during oncolytic reovirus therapy) held by ONCOLYTICS BIOTECH INC. expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/282, A61K31/555, A61K33/243, A61K35/765